PDTI exam 2

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/97

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

98 Terms

1
New cards

When multiple doses are given and steady-state isreached, the amount of drug eliminated during one dosinginterval is equal to the dose.

True

2
New cards

A drug with a relatively small ke (long t1/2) takes a shortertime to reach steady-state than a drug with a large ke.

False. It takes about 5 t1/2 to reach steady-state, so thelonger t1/2 (small ke), the longer it takes to reachsteady-state.

3
New cards

Decreasing the dosing interval while keeping the dose constant will result in lower steady-state concentrations.

False. By decreasing the dosing interval the amount of drug administered per unit time will increase, so steady-state concentrations will increase.

4
New cards

Which of the following dosing regimens will result in the greatest difference between peak and trough concentrations?

Large doses given at a long dosing interval

5
New cards

True or false: as the duration of infusion increases, fluctuation decreases

true

6
New cards

True or false: the rate of infusion does not change between simulations even if the duration is variable

False because it depends on the dose and duration of the infusion and the duration is variable

7
New cards

True or false: Time to reach steady only depends on the half-life of a drug

true

8
New cards

Pharmacogenetics definiton

single gene-drug interaction and how variation in gene impacts an individual's response to a single drug

9
New cards

Pharmacogenomics definition

influence of many genes, or entire genome and how variation of such impacts an individual's response to medication

10
New cards

benefits of PGx interventions

-improve disease outcomes

-decrease adverse effects

-decrease healthcare spending

-get the patient on the right drug sooner

11
New cards

What is the human genome project?

completed in 2003 and was a 13 year project; the goal was to identify all the genes in human DNA

12
New cards

What is the central dogma of biology?

a theory stating that genetic information flows only in one direction, from DNA, to RNA, to protein, or RNA directly to protein.

13
New cards

Genome definition

the entire genetic make-up of an organism

14
New cards

Exome defintion

only the protein coding segments (exons)

15
New cards

Regulome definition

DNA elements that modulate the expression of genes

16
New cards

True or False: Assuming linear kinetics, AUC0-∞ after single dose and AUC0-tau at steady-state are the same for a given drug.

True: At steady state, the AUC during one dosing interval (AUC0-tau) is identical to AUC0-∞ of the first dose.

17
New cards

True or false: Administration of a loading dose will cut the time needed to reach steady-state in half.

False: Steady-state is reached immediately through the use of a loading dose.

18
New cards

True of False: AUC stays the same as long as bioavailibility does not change

True

19
New cards

True or False: the lower the Cmax, the later the tmax

true

20
New cards

If ka<

flip flop kinectics (ke-ka)

21
New cards

What does tmax mean

the time needed to achieve peak concentrations

22
New cards

What is tmax independent of

dose and bioavailability

23
New cards

True or False: The larger the ka, the shorter the tmax, the lower the cmax

False: The larger the ka, the shorter the tmax, the higher the cmax

24
New cards

AUC of oral administration is directly related to what

dose and bioavailability

25
New cards

AUC of oral administration is independent of

Ka

26
New cards

If there is slower absorption, what happens to the fluctuation and the time it takes to reach steady state

The slower the absorption, the less fluctuation and the longer it takes to reach steady state

27
New cards

Are steady-state levels dependent on Ka?

no they are independent

28
New cards

True or false: Absorption of a drug from a tablet involves dissolution of the solid dosage form into GI fluids and diffusion through body fluids and membranes.

true

29
New cards

True or False: The terminal slope of the concentration-time profile following oral administration always provides the elimination rate-constant ke.

False (flip flop kinetics)

30
New cards

True or False: Information on Cmax and tmax is sufficient for determining bioequivalence between 2 drug products

False

31
New cards

How do you find F for oral administration?

take amount absorbed into the systemic circulation/amount of drug given orally

32
New cards

Two drugs are considered pharmaceutical equivalents when

- They contain the same active ingredient(s)

- They are of the same dosage form and route of administration

- They are identical in strength or concentration

33
New cards

According to the 2000 FDA BCS Guidance, which class of compound is most likely to be eligible for BCS biowaivers (waiver of clinical studies)?

Class I (High Permeability, High Solubility) Rapidly dissolving

34
New cards

Which main PK parameters are calculated to evaluate the bioequivalence studies?

AUC and Cmax

35
New cards

Relative bioavailability compares

"when the systemic availability of a drug administered orally, is compared with that of oral standard of same drug"

Example: comparison between a capsule and a tablet

36
New cards

Which of the following statement is INCORRECT:

A. Absolute bioavailability is measured by comparing the respective AUCs after extravascular and intravascular administration

B. The oral formulation of Propanolol that undergoes extensive first-pass metabolism must be administered in much larger doses than the equivalent IV formulation of the same drug

C. A relative bioavailability of 100 means that a drug is completely absorbed

D. The rate of absorption depends on the route of administration and the drug formulation

C

Remember!! The relative bioavailability is used to compare two formulations administered extravascularly. Therefore it means that both formulations have the same bioavailability that may not be 100%

37
New cards

Bioequivalence is accepted when

Log-transformed ratios (test:reference) of Cmax and AUC must pass the two one-sided tests about the 90% confidence interval limits of 0.8 - 1.25 (80 - 125%) of branded drug

38
New cards

What is the systemic availability of drug after extravascular administration in comparison to IV administration?

Absolute bioavailability

39
New cards

What is the ideal trial design for a bioequivalence study?

Randomize, two period, two-sequence, cross over design with adequate washout period

40
New cards

What type of trial design is recommended for drugs with long half-lives?

Parallel study design

41
New cards

What type of trial design is recommended for highly variable drugs (intra-subject variability > 30%)?

Replicate cross over study design

42
New cards

What type of administration is recommended for bioequivalence studies (single or repeated doses)?

Single dose study as it is considered more sensitive in assessing the primary question in a bioequivalence study, i.e., release of the drug substance from the drug product into the systemic circulation.A multiple-dose study is usually not recommended.

43
New cards

Do all strengths require a BE study?

In vivo BE studies needed only for highest strength

44
New cards

What is usually recommended to be measure in a BE study, parent or metabolite?

Parent in most cases

45
New cards

What is usually recommended to be measure in a BE study, enantiomers and/or racemic mixtures?

Racemic mixtures in most cases

46
New cards

untronic/untranslated region

RNA transcription and RNA splicing and processing

47
New cards

Allele

One of two or more versions of a genetic sequence at a particular location in the genome

48
New cards

genotype

an individuals collection of genes

49
New cards

phenotype

observable trait

50
New cards

Hardy-Weinberg equilibrium

States that gene frequencies and genotype frequencies will remain constant from generation to generation in an infinitely large, interbreeding population in which mating is at random and there is no selection, migration or mutilation

51
New cards

HWE equation

p^2 + 2pq + q^2 = 1

52
New cards

If two variants are in high linkage disequilibrium, what does that mean?

they will be inherited together

53
New cards

high linkage disequilibrium values

>0.7-0.8

54
New cards

Halotypes

a combination of alleles or SNPs along a chromosome that tend to be inherited together

55
New cards

Diplotype

two haplotypes that are inherited on a chromosome for a certain gene, or combination of alleles or SNPs

56
New cards

What resource can you find annotations of all of the following items: clinical guidelines, package labels, primary literature?

PharmGKB

57
New cards

CPIC

guidelines for prescribing; Designed to help clinicians understand HOW available genetic test results should be used to optimize drug therapy, NOT whether tests should be ordered

58
New cards

Which of the following phenotypes represents the least amount of enzyme activity?

intermediate metabolizer

59
New cards

CYP metabolism is a part of __________ phase metabolism?

one

60
New cards

is CYP1A2 conserved or polymorphic?

well conserved

61
New cards

Substrates of CYP1A2

olanzapine

duloxetine

caffeine

62
New cards

inhibitors of CYP1A2

Fluvoxamine

63
New cards

inducers of CYP1A2

smoking, rifampin

64
New cards

CYP2A6 genetic info

PM more common in asian population

CYP2A6*4 is no function

65
New cards

substrates of CYP2A6

nicotine

66
New cards

CYP2B6 genetic info

phenotypes include PM, IM, NM, RM, UM

67
New cards

CYP2B6 substrates

Efavirenz

Methadone

Bupropion

68
New cards

CYP2B6 inducers

carbamazepine

efavirenz

rifampin

69
New cards

CYP2C8 polymorphic or conserved

polymorphic

70
New cards

CYP2C8 substrates

Glitazones

71
New cards

CYP2C8 inducers

Rifampin

72
New cards

CYP2C9 2 and 3 allele functions

*2 decreased function

*3 no function

73
New cards

CYP2C9 substrates

warfarin, phenytoin, NSAIDs

74
New cards

CYP2C9 inducers

Rifampin

75
New cards

CYP2C9 inhibitors

fluconazole, amiodarone

76
New cards

CYP2C19 *2, 3, 17 allele function

*2, 3 no function

*17 increased function

77
New cards

CYP2C19 PM phenotype is common in what population

Asian populations

78
New cards

CYP2C19 substrates

Clopidogrel, PPIs, Select SSRIs, Voriconazole

79
New cards

CYP2C19 inhibitors

Fluvoxamine

Fluoxetine

80
New cards

CYP2C19 inducers

rifampin

81
New cards

CYP2D6 substrates

codeine

tramadol

paroxetine

fluvoxamine

82
New cards

CYP2D6 inhibitors

Bupropion

Duloxetine

Quinidine

83
New cards

CYP2D6 inducers

none

84
New cards

CYP3A4 conserved or polymorphic

well conserved

85
New cards

CY3A5 expressers are more common in which population

african americans

86
New cards

CYP3A5 *1 means

expressor

87
New cards

CYP3A5*3 means

non expressor

88
New cards

CYP3A4 substrates

CCBs, midazolam

89
New cards

CYP3A inhibitors

ketoconazole, verapamil

90
New cards

CYP3A5 substrates

tacrolimus

91
New cards

CYP3A inducers

Rifampin, St. John's Wort

92
New cards

UGT1A*28

decreased function allele

93
New cards

UGT1A substrates

bilirubin, irinotecan

94
New cards

UGT1A inhibitors

atazanavir

95
New cards

UGT1A inducer

rifampin

96
New cards

NAT2 slow acetylators

greater neuropathy and hepatitis, faster appearance of antinuclear antibodies, hydralazine induced lupus

97
New cards

NAT2 substrates

Isoniazid

Hydralazine

98
New cards

TPMT substrates

Azathioprine, 6-mercaptopurine